Obermatt

Arkema

PAR:AKE · FR0010313833
ChemicalsX-Large

360

44
EV / EBIT64
Price / Owner Earnings29
Owner Earnings Yield45
Dividend Yield93
Price/Sales81
EV / Gross Profit68
Price/Book83
Return on Capital4
Cash Return on Capital24
Return on Equity18
EBIT Margin7
Gross Profitability7
Cash Conversion96
Accruals75
Owner Earnings Margin28
Sales growth39
Profit Growth71
Long-Term EPS Growth85
Owner Earnings Growth30
Reinvestment27
Price momentum67
Debt load42
Refinancing76
Debt Payback8
Liquidity55
Analyst ratings43
Opinion Changes32
Price Target Upside44
Market mood53
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Arkema clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryFrance
IndustryChemicals
SizeX-Large
TypePublic Company
ExchangeENXTPA
Founded2003
Employees6,169
Websitearkema.com
ISINFR0010313833
Last UpdateApr 2, 2026
Themes
ClimateTechBio-based and Renewable Materials3D PrintingPackaging ServicesIndustrialManufacturingPlastics and Rubber Manufacturing

Description

Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Business Segments The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates. Adhesive Solutions The Adhesive…

Analysis

Middle-of-the-road

Arkema S.A. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 28.6× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 11% yearly growth; analysts expect 18%. The price, in other words, assumes less than the experts do.

The trajectory is moderate and the balance sheet is adequate. The company scores 8/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
94
2023202420252026

All-time high

98

Jan 2024

All-time low

39

Feb 2026

Average rank

76

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
81
62
59
55
Price/Earnings
66
97
91
54
Price/Book
83
74
65
65
Dividend Yield
93
88
80
84
Value (overall)
97
100
92
86

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Arkema with its peers
Clariant
VTX:CLN
26
CountrySwitzerland
IndustryChemicals
SizeLarge
Full Stock Analysis →
Lanxess
GER:LXS
4
CountryGermany
IndustryChemicals
SizeLarge
Full Stock Analysis →
EMS-Chemie
SWX:EMSN
56
CountrySwitzerland
IndustryChemicals
SizeLarge
Full Stock Analysis →
Wacker Chemie
GER:WCH
7
CountryGermany
IndustryChemicals
SizeLarge
Full Stock Analysis →
Synthomer
LSE:SYNT
28
CountryUK
IndustryChemicals
SizeMedium
Full Stock Analysis →
Elementis
LSE:ELM
48
CountryUK
IndustryChemicals
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →